These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


306 related items for PubMed ID: 1680777

  • 1. Drug-induced parkinsonism: relationship to age at onset of schizophrenia.
    Sandyk R, Kay SR.
    Funct Neurol; 1991; 6(2):151-7. PubMed ID: 1680777
    [Abstract] [Full Text] [Related]

  • 2. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.
    Andrew HG.
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668
    [Abstract] [Full Text] [Related]

  • 3. Risk factors for drug-induced parkinsonism in tardive dyskinesia patients.
    Hansen TE, Brown WL, Weigel RM, Casey DE.
    J Clin Psychiatry; 1988 Apr; 49(4):139-41. PubMed ID: 2895762
    [Abstract] [Full Text] [Related]

  • 4. HLA antigens in drug-induced parkinsonism.
    Metzer WS, Newton JE, Steele RW, Claybrook M, Paige SR, McMillan DE, Hays S.
    Mov Disord; 1989 Apr; 4(2):121-8. PubMed ID: 2567491
    [Abstract] [Full Text] [Related]

  • 5. Absence of neuroleptic-induced parkinsonism in psychotic patients receiving adjunctive electroconvulsive therapy.
    Mukherjee S, Debsikdar V.
    Convuls Ther; 1994 Mar; 10(1):53-8. PubMed ID: 7914462
    [Abstract] [Full Text] [Related]

  • 6. Negative symptoms, tardive dyskinesia and depression in chronic schizophrenia.
    Barnes TR, Liddle PF, Curson DA, Patel M.
    Br J Psychiatry Suppl; 1989 Nov; (7):99-103. PubMed ID: 2575915
    [No Abstract] [Full Text] [Related]

  • 7. Vulnerability to tardive dyskinesia.
    Wolf ME, DeWolfe AS, Ryan JJ, Lips O, Mosnaim AD.
    J Clin Psychiatry; 1985 Sep; 46(9):367-8. PubMed ID: 2863257
    [Abstract] [Full Text] [Related]

  • 8. [Neuroleptics and nicotine].
    Erdmann R.
    Psychiatr Prax; 1995 Nov; 22(6):223-7. PubMed ID: 8570751
    [Abstract] [Full Text] [Related]

  • 9. The clinical association of tardive dyskinesia and drug-induced parkinsonism.
    Wolf ME, Chevesich J, Lehrer E, Mosnaim AD.
    Biol Psychiatry; 1983 Oct; 18(10):1181-8. PubMed ID: 6140032
    [No Abstract] [Full Text] [Related]

  • 10. The psychological consequences of tardive dyskinesia. The effect of drug-induced parkinsonism and the topography of the dyskinetic movements.
    Brown KW, White T.
    Br J Psychiatry; 1991 Sep; 159():399-403. PubMed ID: 1683594
    [Abstract] [Full Text] [Related]

  • 11. Tardive dyskinesia, mild drug-induced dyskinesia, and drug-induced parkinsonism: risk factors and topographic distribution.
    Akbostanci MC, Atbaşoğlu EC, Balaban H.
    Acta Neurol Belg; 1999 Sep; 99(3):176-81. PubMed ID: 10544725
    [Abstract] [Full Text] [Related]

  • 12. "Positive" and "negative" movement disorders in schizophrenia.
    Sandyk R, Kay SR.
    Int J Neurosci; 1992 Oct; 66(3-4):143-51. PubMed ID: 1305614
    [Abstract] [Full Text] [Related]

  • 13. Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions.
    Dean CE, Kuskowski MA, Caligiuri MP.
    J Clin Psychopharmacol; 2006 Dec; 26(6):560-5. PubMed ID: 17110811
    [Abstract] [Full Text] [Related]

  • 14. Comparison of severe and mild tardive dyskinesia: implications for etiology.
    Gardos G, Cole JO, Schniebolk S, Salomon M.
    J Clin Psychiatry; 1987 Sep; 48(9):359-62. PubMed ID: 2887550
    [Abstract] [Full Text] [Related]

  • 15. The association among negative symptoms, movement disorders, and frontal lobe psychological deficits in schizophrenic patients.
    Brown KW, White T.
    Biol Psychiatry; 1991 Dec 15; 30(12):1182-90. PubMed ID: 1686411
    [Abstract] [Full Text] [Related]

  • 16. Tardive dyskinesia and positive symptoms of schizophrenia.
    White T, Brown KW, Woods JP.
    Acta Psychiatr Scand; 1991 May 15; 83(5):377-9. PubMed ID: 1677232
    [Abstract] [Full Text] [Related]

  • 17. Tardive and chronically recurrent oculogyric crises.
    Sachdev P.
    Mov Disord; 1993 May 15; 8(1):93-7. PubMed ID: 8093550
    [Abstract] [Full Text] [Related]

  • 18. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
    Ghadirian AM, Annable L, Bélanger MC, Chouinard G.
    J Clin Psychiatry; 1996 Jan 15; 57(1):22-8. PubMed ID: 8543543
    [Abstract] [Full Text] [Related]

  • 19. Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation.
    Schultz SK, Miller DD, Arndt S, Ziebell S, Gupta S, Andreasen NC.
    Biol Psychiatry; 1995 Dec 01; 38(11):713-9. PubMed ID: 8580223
    [Abstract] [Full Text] [Related]

  • 20. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
    Ganzini L, Casey DE, Hoffman WF, McCall AL.
    Arch Intern Med; 1993 Jun 28; 153(12):1469-75. PubMed ID: 8512437
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.